Moderna has secured a contract with Brazil’s Ministry of Health to supply 12.5 million doses of its mRNA COVID-19 vaccine targeting the XBB.1.5 sublineage. The agreement marks Moderna’s first-time contribution to Brazil’s vaccination efforts. The vaccine is expected to be delivered in the second quarter of 2024.